![](/img/cover-not-exists.png)
PDB61 HEALTH CARE COSTS AND UTILIZATION ASSOCIATED WITH TREATMENT MODIFICATION IN TYPE-2 DIABETES MELLITUS (T2DM) PATIENTS TAKING ORAL ANTI-DIABETIC DRUGS (OADS)
G Krishnarajah, MJ Bhosle, R ChapmanVolume:
12
Year:
2009
Language:
english
DOI:
10.1016/s1098-3015(10)73604-4
File:
PDF, 92 KB
english, 2009